Reuters logo
BRIEF-Takeda, Schrödinger announce multi-year, multi-target research collaboration
July 20, 2017 / 1:25 PM / 5 months ago

BRIEF-Takeda, Schrödinger announce multi-year, multi-target research collaboration

July 20 (Reuters) - Takeda Pharmaceutical Co Ltd:

* Takeda and Schrödinger announce multi-year, multi-target research collaboration

* Says under novel collaboration approach, Schrödinger will autonomously lead discovery efforts

* Says under terms of collaboration, Takeda will have option to exclusively license programs from Schrödinger

* Takeda Pharmaceutical Co Ltd - additional financial details are not being disclosed

* Takeda Pharmaceutical - economic terms include pre-clinical, clinical, and commercial milestones of up to $170 million per program, as well as royalties on future sales Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below